Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001238483 | SCV001411297 | likely benign | Saldino-Mainzer syndrome | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002480779 | SCV002780450 | uncertain significance | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2021-12-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003263877 | SCV003966915 | uncertain significance | Inborn genetic diseases | 2023-04-05 | criteria provided, single submitter | clinical testing | The c.3989C>T (p.A1330V) alteration is located in exon 29 (coding exon 27) of the IFT140 gene. This alteration results from a C to T substitution at nucleotide position 3989, causing the alanine (A) at amino acid position 1330 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003456484 | SCV004184496 | uncertain significance | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | IFT140: PM5, BP4 |